Breast Radiotherapy: Less is More?

被引：25

作者：

Coles, C. E. ^{[1
]}

Brunt, A. M. ^{[2
]}

Wheatley, D. ^{[3
]}

Mukesh, M. B. ^{[1
]}

Yarnold, J. R. ^{[4
,5
]}

机构：

[1] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England

[2] Univ Hosp N Staffordshire NHS Trust, Stoke On Trent, Staffs, England

[3] Royal Cornwall Hosp NHS Trust, Truro, England

[4] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[5] Inst Canc Res, Sutton, Surrey, England

来源：

CLINICAL ONCOLOGY | 2013年 / 25卷 / 02期

基金：

英国医学研究理事会;

关键词：

Breast cancer; clinical trials; radiotherapy; TARGETED INTRAOPERATIVE RADIOTHERAPY; CONSERVING THERAPY; WHOLE-BREAST; HYPOFRACTIONATED RADIOTHERAPY; UK STANDARDIZATION; RADIATION-THERAPY; SURGICAL CLIPS; DOSE-RESPONSE; NORMAL TISSUE; CANCER;

D O I：

10.1016/j.clon.2012.10.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A 3 week schedule of whole breast radiotherapy is firmly established in the UK and is becoming more accepted internationally, especially as accelerated partial breast radiotherapy regimens become more common. It seems that a 3 week schedule is unlikely to be the lower limit of whole breast hypofractionation and the partial breast may even be adequately treated with just a single treatment. It is, however, essential that these hypotheses are rigorously tested within well-designed trials to ensure the highest quality of radiotherapy. This overview will address the rationale for hypofractionation in breast cancer, discuss past trials and outline the design of current studies. (c) 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：127 / 134

页数：8

共 50 条

[21] Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results
Plataniotis, Georgios A.
Theofanopoulou, Maria-Aikaterini
Sotiriadou, Konstantinia
Kyrgias, Georgios
BREAST CANCER, 2010, 17 (01) : 42 - 47
[22] Stereotactic beam radiotherapy for prostate cancer: is less, more?
Miralbell, Raymond
LANCET ONCOLOGY, 2019, 20 (11) : 1471 - 1472
[23] Australian survey on current practices for breast radiotherapy
Dundas, Kylie L.
Pogson, Elise M.
Batumalai, Vikneswary
Boxer, Miriam M.
Yap, Mei Ling
Delaney, Geoff P.
Metcalfe, Peter
Holloway, Lois
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (06) : 736 - 742
[24] Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues
Yarnold, John
Somaiah, Navita
Bliss, Judith M.
BREAST, 2015, 24 : S108 - S113
[25] A review of setup error in supine breast radiotherapy using cone -beam computed tomography
Batumalai, Vikneswary
Holloway, Lois
Delaney, Geoff P.
MEDICAL DOSIMETRY, 2016, 41 (03) : 225 - 229
[26] New innovative techniques in radiotherapy for breast cancer
Murphy, J. O.
Sacchini, V. S.
MINERVA CHIRURGICA, 2013, 68 (02) : 139 - 154
[27] Locoregional breast radiotherapy and concurrent treatment with trastuzumab
Jacob, Julian
Kirova, Youlia M.
BULLETIN DU CANCER, 2014, 101 (01) : 40 - 51
[28] Radiotherapy Issues in Elderly Breast Cancer Patients
Kunkler, Ian
BREAST CARE, 2012, 7 (06) : 453 - 459
[29] Breast Cancer Radiotherapy-induced Cardiotoxicity
Nurlu, Dilek
Cosar, Rusen
Parlar, Sule
Uzal, Cem
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2022, 37 (02): : 35 - 43
[30] Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer
Meattini, Icro
Guenzi, Marina
Fozza, Alessandra
Vidali, Cristiana
Rovea, Paolo
Meacci, Fiammetta
Livi, Lorenzo
BREAST CANCER, 2017, 24 (01) : 52 - 62

← 1 2 3 4 5 →